Document Detail


Cardiovascular and metabolic effects of obesity.
MedLine Citation:
PMID:  18307732     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Obesity is an important risk factor for hypertension and its incidence is increasing around the world. 2. The mechanisms underlying obesity-related hypertension include sympathetic activation, altered vascular responses, hormonal changes, enhanced inflammatory markers and structural changes. 3. This review summarizes recent evidence of the underlying impact of obesity on blood pressure. A number of candidate mechanisms include increased sympathetic activity, activation of the renin-angiotensin system, altered vasoconstrictor or dilator responses and the attendant systemic inflammatory state. 4. While adult lifestyle factors undoubtedly contribute to the incidence of obesity and its attendant hypertension, evidence suggests that the programming of obesity may occur following over-nutrition during development. A growing body of evidence links maternal obesity, offspring obesity and hypertension. 5. Finally, epigenetic modification of genes relevant to hypertension may contribute to the development of hypertension following a suboptimal intrauterine environment. To date the cardiovascular effects of early nutritional changes have been largely investigated following maternal under-nutrition or protein restriction; further work is necessary to determine the impact of maternal obesity.
Authors:
Margaret J Morris
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  35     ISSN:  1440-1681     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-02-29     Completed Date:  2008-05-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  416-9     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia. m.morris@unsw.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cardiovascular Diseases / metabolism*
Energy Metabolism / physiology*
Humans
Hypertension / metabolism
Obesity / metabolism*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Time-course reduction of renal function in rats on high sodium intake: acute reversal by potassium c...
Next Document:  Angiotensin converting enzyme 2 in the kidney.